RENNOVA HEALTH, INC. (NASDAQ:RNVA) Files An 8-K Other EventsItem 8.01. Other Events.
On August 28, 2017, the Company issued a press release announcing the issuance of a letter to stockholders from Seamus Lagan, Chief Executive Officer.
Item 9.01. Financial Statements and Exhibits.
(d)
| Exhibit No. | Exhibit Description |
| 99.1 | Press Release dated August 28, 2017 |
Rennova Health, Inc. ExhibitEX-99.1 2 ex99-1.htm Rennova Health ISSUES LETTER TO STOCKHOLDERS WEST PALM BEACH,…To view the full exhibit click here
About RENNOVA HEALTH, INC. (NASDAQ:RNVA)
Rennova Health, Inc. (Rennova), formerly CollabRx, Inc., is a provider of diagnostics and supportive software solutions to healthcare providers. The Company operates in three segments: clinical laboratory operations, supportive software solutions, and decision support and informatics operations. The Company is a healthcare enterprise that delivers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management and intends to provide financial services, to medical providers. Rennova’s principal line of business is clinical laboratory blood and urine testing services. It is also engaged in the provision of urine drug toxicology testing to physicians, clinics and rehabilitation facilities in the United States. Its clinical laboratories include Biohealth Medical Laboratory, Inc.; Alethea Laboratories, Inc.; International Technologies, LLC; EPIC Reference Labs, Inc., and Epinex Diagnostics Laboratories, Inc.